{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:20:22Z","timestamp":1789687222615,"version":"4.0.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["KJ2021A0336"],"award-info":[{"award-number":["KJ2021A0336"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s12010-024-05054-7","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T08:02:41Z","timestamp":1724918561000},"page":"570-586","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Knockdown of HM13 Inhibits Metastasis, Proliferation, and M2 Macrophage Polarization of Non-small Cell Lung Cancer Cells by Suppressing the JAK2\/STAT3 Signaling Pathway"],"prefix":"10.1007","volume":"197","author":[{"given":"Dashu","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"key":"5054_CR1","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","volume":"144","author":"J Ferlay","year":"2019","unstructured":"Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Pi\u00f1eros, M., Znaor, A., & Bray, F. (2019). Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. International Journal of Cancer, 144, 1941\u20131953.","journal-title":"International Journal of Cancer"},{"key":"5054_CR2","first-page":"7","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel, R. L., Miller, K. D., & Jemal, A. (2019). Cancer statistics, 2019. CA: A Cancer Journal for Clinicians, 69, 7\u201334.","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"5054_CR3","doi-asserted-by":"publisher","first-page":"550002","DOI":"10.3389\/fonc.2020.550002","volume":"10","author":"J Xu","year":"2020","unstructured":"Xu, J., Nie, H., He, J., Wang, X., Liao, K., Tu, L., & Xiong, Z. (2020). Using machine learning modeling to explore new immune-related prognostic markers in non-small cell lung cancer. Frontiers in Oncology, 10, 550002.","journal-title":"Frontiers in Oncology"},{"key":"5054_CR4","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.mayocp.2019.01.013","volume":"94","author":"N Duma","year":"2019","unstructured":"Duma, N., Santana-Davila, R., & Molina, J. R. (2019). Non-small cell lung cancer: Epidemiology, screening, diagnosis, and treatment. Mayo Clinic Proceedings, 94, 1623\u20131640.","journal-title":"Mayo Clinic Proceedings"},{"key":"5054_CR5","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis, W. D., Brambilla, E., Nicholson, A. G., Yatabe, Y., Austin, J. H. M., Beasley, M. B., Chirieac, L. R., Dacic, S., Duhig, E., Flieder, D. B., Geisinger, K., Hirsch, F. R., Ishikawa, Y., Kerr, K. M., Noguchi, M., Pelosi, G., Powell, C. A., Tsao, M. S., & Wistuba, I. (2015). The 2015 World Health Organization classification of lung tumors: Impact of genetic, clinical and radiologic advances since the 2004 classification. Journal of Thoracic Oncology\u202f: Official Publication of the International Association for the Study of Lung Cancer, 10, 1243\u20131260.","journal-title":"Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer"},{"key":"5054_CR6","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.1002\/cam4.4081","volume":"10","author":"W Sun","year":"2021","unstructured":"Sun, W., Li, S., Tang, G., Sun, S., Luo, Y., Bai, R., Han, L., Jiang, X., Gao, Y., Huang, Z., Zhang, J., Gong, Y., & Xie, C. (2021). HHLA2 deficiency inhibits non-small cell lung cancer progression and THP-1 macrophage M2 polarization. Cancer Medicine, 10, 5256\u20135269.","journal-title":"Cancer Medicine"},{"key":"5054_CR7","doi-asserted-by":"publisher","first-page":"20908","DOI":"10.18632\/oncotarget.24556","volume":"9","author":"AE de Groot","year":"2018","unstructured":"de Groot, A. E., & Pienta, K. J. (2018). Epigenetic control of macrophage polarization: Implications for targeting tumor-associated macrophages. Oncotarget, 9, 20908\u201320927.","journal-title":"Oncotarget"},{"key":"5054_CR8","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","volume":"19","author":"DG DeNardo","year":"2019","unstructured":"DeNardo, D. G., & Ruffell, B. (2019). Macrophages as regulators of tumour immunity and immunotherapy. Nature Reviews. Immunology, 19, 369\u2013382.","journal-title":"Nature Reviews. Immunology"},{"key":"5054_CR9","doi-asserted-by":"publisher","unstructured":"Liu, Y., & Cao, X. (2015). The origin and function of tumor-associated macrophages. Cellular & Molecular Immunology, 12(1), 1\u20134. https:\/\/doi.org\/10.1038\/cmi.2014.83","DOI":"10.1038\/cmi.2014.83"},{"key":"5054_CR10","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1615\/CritRevImmunol.v32.i6.10","volume":"32","author":"CD Mills","year":"2012","unstructured":"Mills, C. D. (2012). M1 and M2 macrophages: Oracles of health and disease. Critical Reviews in Immunology, 32, 463\u2013488.","journal-title":"Critical Reviews in Immunology"},{"key":"5054_CR11","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.cellsig.2013.11.004","volume":"26","author":"D Zhou","year":"2014","unstructured":"Zhou, D., Huang, C., Lin, Z., Zhan, S., Kong, L., Fang, C., & Li, J. (2014). Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways. Cellular Signalling, 26, 192\u2013197.","journal-title":"Cellular Signalling"},{"key":"5054_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"Noy, R., & Pollard, J. W. (2014). Tumor-associated macrophages: From mechanisms to therapy. Immunity, 41, 49\u201361.","journal-title":"Immunity"},{"key":"5054_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","volume":"141","author":"BZ Qian","year":"2010","unstructured":"Qian, B. Z., & Pollard, J. W. (2010). Macrophage diversity enhances tumor progression and metastasis. Cell, 141, 39\u201351.","journal-title":"Cell"},{"key":"5054_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.it.2011.12.001","volume":"33","author":"B Ruffell","year":"2012","unstructured":"Ruffell, B., Affara, N. I., & Coussens, L. M. (2012). Differential macrophage programming in the tumor microenvironment. Trends in Immunology, 33, 119\u2013126.","journal-title":"Trends in Immunology"},{"key":"5054_CR15","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1016\/j.bbamem.2013.03.033","volume":"1828","author":"M Voss","year":"2013","unstructured":"Voss, M., Schr\u00f6der, B., & Fluhrer, R. (2013). Mechanism, specificity, and physiology of signal peptide peptidase (SPP) and SPP-like proteases. Biochimica et Biophysica Acta, 1828, 2828\u20132839.","journal-title":"Biochimica et Biophysica Acta"},{"key":"5054_CR16","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/s41419-022-05154-4","volume":"13","author":"H Yang","year":"2022","unstructured":"Yang, H., Li, Z., Wang, Z., Zhang, X., Dai, X., Zhou, G., & Ding, Q. (2022). Histocompatibility Minor 13 (HM13), targeted by miR-760, exerts oncogenic role in breast cancer by suppressing autophagy and activating PI3K-AKT-mTOR pathway. Cell Death & Disease, 13, 728.","journal-title":"Cell Death & Disease"},{"key":"5054_CR17","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1038\/s41388-018-0539-y","volume":"38","author":"FF Hsu","year":"2019","unstructured":"Hsu, F. F., Chou, Y. T., Chiang, M. T., Li, F. A., Yeh, C. T., Lee, W. H., & Chau, L. Y. (2019). Signal peptide peptidase promotes tumor progression via facilitating FKBP8 degradation. Oncogene, 38, 1688\u20131701.","journal-title":"Oncogene"},{"key":"5054_CR18","doi-asserted-by":"publisher","first-page":"6441","DOI":"10.4049\/jimmunol.167.11.6441","volume":"167","author":"MK Lemberg","year":"2001","unstructured":"Lemberg, M. K., Bland, F. A., Weihofen, A., Braud, V. M., & Martoglio, B. (2001). Intramembrane proteolysis of signal peptides: An essential step in the generation of HLA-E epitopes. Journal of Immunology (Baltimore, Md.\u202f: 1950), 167, 6441\u20136446.","journal-title":"Journal of Immunology (Baltimore, Md. : 1950)"},{"key":"5054_CR19","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0092-8674(00)80675-3","volume":"100","author":"MS Brown","year":"2000","unstructured":"Brown, M. S., Ye, J., Rawson, R. B., & Goldstein, J. L. (2000). Regulated intramembrane proteolysis: A control mechanism conserved from bacteria to humans. Cell, 100, 391\u2013398.","journal-title":"Cell"},{"key":"5054_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/cns.12672","volume":"23","author":"JW Wei","year":"2017","unstructured":"Wei, J. W., Cai, J. Q., Fang, C., Tan, Y. L., Huang, K., Yang, C., Chen, Q., Jiang, C. L., & Kang, C. S. (2017). Signal peptide peptidase, encoded by HM13, contributes to tumor progression by affecting EGFRvIII secretion profiles in glioblastoma. CNS Neuroscience & Therapeutics, 23, 257\u2013265.","journal-title":"CNS Neuroscience & Therapeutics"},{"key":"5054_CR21","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1186\/s12885-022-09987-2","volume":"22","author":"G Zhang","year":"2022","unstructured":"Zhang, G., Lv, X., Yang, Q., & Liu, H. (2022). Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma. BMC Cancer, 22, 888.","journal-title":"BMC Cancer"},{"key":"5054_CR22","doi-asserted-by":"publisher","first-page":"7067743","DOI":"10.1155\/2022\/7067743","volume":"2022","author":"RQ Zong","year":"2022","unstructured":"Zong, R. Q., Zhang, H. Y., Li, X. Y., Li, Y. R., & Chen, Y. (2022). Overexpressed histocompatibility minor 13 was associated with liver hepatocellular carcinoma progression and prognosis. Genetics Research, 2022, 7067743.","journal-title":"Genetics Research"},{"key":"5054_CR23","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li, T., Fu, J., Zeng, Z., Cohen, D., Li, J., Chen, Q., Li, B., & Liu, X. S. (2020). TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Research, 48, W509-w514.","journal-title":"Nucleic Acids Research"},{"key":"5054_CR24","doi-asserted-by":"crossref","unstructured":"Zong, R. Q., Zhang, H. Y., Li, X. Y., & Li, Y. R. (2022). Overexpressed histocompatibility minor 13 was associated with liver hepatocellular carcinoma progression and prognosis. 2022, 7067743.","DOI":"10.1155\/2022\/7067743"},{"key":"5054_CR25","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J., & Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, Calif.), 25, 402\u2013408.","journal-title":"Methods (San Diego, Calif.)"},{"key":"5054_CR26","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1080\/10717544.2022.2057617","volume":"29","author":"H Xie","year":"2022","unstructured":"Xie, H., Yao, J., Wang, Y., & Ni, B. (2022). Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3\/SOX2 axis. Drug Delivery, 29, 1257\u20131271.","journal-title":"Drug Delivery"},{"key":"5054_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.abb.2018.09.013","volume":"660","author":"M Zhang","year":"2018","unstructured":"Zhang, M., Wu, J., Zhong, W., Zhao, Z., & Liu, Z. (2018). Long non-coding RNA BRE-AS1 represses non-small cell lung cancer cell growth and survival via up-regulating NR4A3. Archives of Biochemistry and Biophysics, 660, 53\u201363.","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"5054_CR28","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.omto.2022.01.012","volume":"24","author":"W Chen","year":"2022","unstructured":"Chen, W., Tang, D., Lin, J., Huang, X., Lin, S., Shen, G., & Dai, Y. (2022). Exosomal circSHKBP1 participates in non-small cell lung cancer progression through PKM2-mediated glycolysis. Molecular Therapy Oncolytics, 24, 470\u2013485.","journal-title":"Molecular Therapy Oncolytics"},{"key":"5054_CR29","doi-asserted-by":"publisher","first-page":"728575","DOI":"10.3389\/fmed.2021.728575","volume":"8","author":"W Gu","year":"2021","unstructured":"Gu, W., Hu, M., Xu, L., Ren, Y., Mei, J., Wang, W., & Wang, C. (2021). The Ki-67 proliferation index-related nomogram to predict the response of first-line tyrosine kinase inhibitors or chemotherapy in non-small cell lung cancer patients with epidermal growth factor receptor-mutant status. Frontiers in Medicine, 8, 728575.","journal-title":"Frontiers in Medicine"},{"key":"5054_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/cancers9120171","volume":"9","author":"T Vu","year":"2017","unstructured":"Vu, T., & Datta, P. K. (2017). Regulation of EMT in colorectal cancer: A culprit in metastasis. Cancers, 9, 171.","journal-title":"Cancers"},{"key":"5054_CR31","doi-asserted-by":"publisher","first-page":"950156","DOI":"10.3389\/fphar.2022.950156","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu, J., Li, W., & Wu, L. (2022). Pan-cancer analysis suggests histocompatibility minor 13 is an unfavorable prognostic biomarker promoting cell proliferation, migration, and invasion in hepatocellular carcinoma. Frontiers in Pharmacology, 13, 950156.","journal-title":"Frontiers in Pharmacology"},{"key":"5054_CR32","first-page":"3858","volume":"16","author":"H Liu","year":"2018","unstructured":"Liu, H., Dong, H., Jiang, L., Li, Z., & Ma, X. (2018). Bleomycin inhibits proliferation and induces apoptosis in TPC-1 cells through reversing M2-macrophages polarization. Oncology Letters, 16, 3858\u20133866.","journal-title":"Oncology Letters"},{"key":"5054_CR33","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1084\/jem.20150295","volume":"212","author":"A Mantovani","year":"2015","unstructured":"Mantovani, A., & Allavena, P. (2015). The interaction of anticancer therapies with tumor-associated macrophages. The Journal of Experimental Medicine, 212, 435\u2013445.","journal-title":"The Journal of Experimental Medicine"},{"key":"5054_CR34","doi-asserted-by":"crossref","unstructured":"Guo, Z., Song, J., Hao, J., Zhao, H., Du, X., Li, E., & Kuang, Y. (2019). M2 macrophages promote NSCLC metastasis by upregulating CRYAB. 10, 377.","DOI":"10.1038\/s41419-019-1618-x"},{"key":"5054_CR35","doi-asserted-by":"publisher","first-page":"2311231","DOI":"10.1155\/2023\/2311231","volume":"2023","author":"M Yang","year":"2023","unstructured":"Yang, M., Zhou, W., Xu, M., Han, X., Shi, Y., Shi, M., & Wang, Z. (2023). Tumor suppressor miR-613 alleviates non-small cell lung cancer cell via repressing M2 macrophage polarization. Journal of Oncology, 2023, 2311231.","journal-title":"Journal of Oncology"},{"key":"5054_CR36","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1177\/030089160308900501","volume":"89","author":"A Mantovani","year":"2003","unstructured":"Mantovani, A., Schioppa, T., Biswas, S. K., Marchesi, F., Allavena, P., & Sica, A. (2003). Tumor-associated macrophages and dendritic cells as prototypic type II polarized myeloid populations. Tumori, 89, 459\u2013468.","journal-title":"Tumori"},{"key":"5054_CR37","doi-asserted-by":"publisher","first-page":"5995","DOI":"10.1002\/jcp.29525","volume":"235","author":"Y Chen","year":"2020","unstructured":"Chen, Y., Shao, Z., Jiang, E., Zhou, X., Wang, L., Wang, H., Luo, X., Chen, Q., Liu, K., & Shang, Z. (2020). CCL21\/CCR7 interaction promotes EMT and enhances the stemness of OSCC via a JAK2\/STAT3 signaling pathway. Journal of Cellular Physiology, 235, 5995\u20136009.","journal-title":"Journal of Cellular Physiology"},{"key":"5054_CR38","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1146\/annurev-med-051113-024537","volume":"66","author":"JJ O'Shea","year":"2015","unstructured":"O\u2019Shea, J. J., Schwartz, D. M., Villarino, A. V., Gadina, M., McInnes, I. B., & Laurence, A. (2015). The JAK-STAT pathway: Impact on human disease and therapeutic intervention. Annual Review of Medicine, 66, 311\u2013328.","journal-title":"Annual Review of Medicine"},{"key":"5054_CR39","doi-asserted-by":"publisher","unstructured":"Jin, Y., Kang, Y., Wang, M., Wu, B., Su, B., Yin, H., Tang, Y., Li, Q., Wei, W., Mei, Q., Hu, G., Lukacs-Kornek, V., Li, J., Wu, K., Yuan, X., & Wang, W. (2022). Targeting polarized phenotype of microglia via IL6\/JAK2\/STAT3 signaling to reduce NSCLC brain metastasis. Signal Transduction and Targeted Therapy, 7(1), 52. https:\/\/doi.org\/10.1038\/s41392-022-00872-9","DOI":"10.1038\/s41392-022-00872-9"},{"key":"5054_CR40","doi-asserted-by":"publisher","first-page":"803","DOI":"10.21037\/atm-21-1669","volume":"9","author":"X Zheng","year":"2021","unstructured":"Zheng, X., Zhu, Y., Wang, X., Hou, Y., & Fang, Y. (2021). Silencing of ITGB6 inhibits the progression of cervical carcinoma via regulating JAK\/STAT3 signaling pathway. Annals of Translational Medicine, 9, 803.","journal-title":"Annals of Translational Medicine"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-024-05054-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-024-05054-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-024-05054-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T10:06:42Z","timestamp":1737108402000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-024-05054-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["5054"],"URL":"https:\/\/doi.org\/10.1007\/s12010-024-05054-7","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,29]]},"assertion":[{"value":"19 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study had approval of Chaohu Hospital of Anhui Medical University Ethics and Research Committees (approval number: KYXM-202302\u2013002). The animal ethics board of Beijing Viewsolid Biotechnology Co. LTD reviewed and approved all animal procedures (approval number: VS212601470).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All the patients involved in the study had provided written consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}